ARCHIVES

Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of August

August 29, 2014

Pittsburgh, Norris Win Bristol-Myers Unrestricted Grants

April 19, 1991

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

Program Announcement For Clinical Research

February 29, 1980

Funding Opportunities

December 6, 2002